Alessandra A.
- Country
- Italy
- Department
- Oncologia Medica
Research Overview
- Evaluation of Atezolizumab and Bevacizumab, with or without Tiragolumab, in Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma
- Evaluation of Sequential Versus Up-Front Administration of Durvalumab, Tremelimumab, and Bevacizumab in Non-Resectable Hepatocellular Carcinoma
- Phase IIIb Randomized Multicenter Open-Label Trial of Atezolizumab and Bevacizumab Versus Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma
Data & Insights
Has run more than one trial at 12 of 96 partner sites.
Specializations
Liver Cancer Research
Specializes in investigating innovative treatments for hepatocellular carcinoma (HCC), with particular emphasis on both intermediate-stage and advanced disease states. The investigator's work encompasses various therapeutic approaches for non-resectable cases.
- Advanced HCC Treatment Protocols
- Intermediate-Stage HCC Management
- Combination Immunotherapy Approaches
Focuses on evaluating novel therapeutic combinations including immunotherapy and targeted treatments for liver cancer patients.
Biliary Tract Oncology
Conducts research in the treatment of locally advanced cholangiocarcinoma, with specific interest in neo-adjuvant therapeutic strategies. The investigator explores innovative pre-operative treatment approaches.
- Neo-adjuvant Therapy Development
- Surgical Outcome Optimization
- Translational Research in Cholangiocarcinoma
Investigates combined immunotherapy approaches in the pre-operative setting for biliary tract cancers.
Immunotherapy Innovation
Pioneers research in combination immunotherapy strategies for gastrointestinal cancers, including the integration of immune checkpoint inhibitors with targeted therapies. Evaluates novel therapeutic combinations to enhance treatment efficacy.
- Immune Checkpoint Inhibitor Combinations
- Anti-angiogenic Treatment Approaches
- Multi-modal Treatment Strategies
Studies the integration of various immunotherapeutic agents with established treatment modalities.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.